| Angela Renee Arthurs, DPT | |
|
525 E Market St, Akron, OH 44304-1619 | |
| (330) 375-3000 | |
| Not Available |
| Full Name | Angela Renee Arthurs |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 525 E Market St, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285055640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 013778 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Renee Arthurs, DPT 525 E Market St, Akron, OH 44304-1619 Ph: (330) 375-3000 | Angela Renee Arthurs, DPT 525 E Market St, Akron, OH 44304-1619 Ph: (330) 375-3000 |
News Archive
A University of Manchester researcher has developed a treatment for lower back pain using the patient's own stem cells, which could replace the use of strong painkillers or surgery that can cause debilitation, neither of which addresses the underlying cause.
Scientists have demonstrated a new way of re-engineering the body's immune system to target cancer, paving the way for a new generation of drugs, unprecedented in safety and effectiveness.
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic disease to improve progression-free survival (PFS).
Bacterial exposure has been identified as a potential environmental risk factor in developing coeliac disease, a hereditary autoimmune-like condition that affects about one in 70 Australians.
Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.
› Verified 4 days ago
Kathy J Peterson, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 640 W Market St, Akron, OH 44303 Phone: 330-762-5425 | |
Cortney Ann Myer, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-2110 | |
Rehabilitation And Health Center Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1799 Akron Peninsula Rd, Suite 312, Akron, OH 44313 Phone: 330-752-7265 | |
Dr. Brenda Renee Runion, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-6190 | |
Dr. Michael John Golz, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-4854 Fax: 330-375-4074 | |
Lisa Dietsche, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 640 W Market St, Akron, OH 44303 Phone: 330-762-5425 | |
Michael Green, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3367 |